Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:55-61
Published online before print December 2, 2002, doi: 10.1161/01.CIR.0000043260.82447.62
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/1/55    most recent
01.CIR.0000043260.82447.62v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cipollone, F.
Right arrow Articles by Patrignani, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cipollone, F.
Right arrow Articles by Patrignani, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETYLSALICYLIC ACID
*METHYLPREDNISOLONE
Medline Plus Health Information
*Steroids
Related Collections
Right arrow Pathophysiology
Right arrow Acute coronary syndromes
Right arrow Antiplatelets
Right arrow Platelets
Right arrow Mechanism of atherosclerosis/growth factors

(Circulation. 2003;107:55.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Modulation of Aspirin-Insensitive Eicosanoid Biosynthesis by 6-Methylprednisolone in Unstable Angina

Francesco Cipollone, MD; Antonina Ganci, MD; Anita Greco, PhD; Maria Rosaria Panara, PhD; Massimo Pasquale, MD; Domenico Di Gregorio, MD; Ettore Porreca, MD; Andrea Mezzetti, MD; Franco Cuccurullo, MD; Paola Patrignani, PhD

From the Department of Medicine and Aging (F. Cipollone, A. Ganci, A. Greco, M.R.P., E.P., A.M., F. Cuccurullo, P.P.) and the Center for the Prevention of Atherosclerosis (F. Cipollone, A.M., F. Cuccurullo), University of Chieti "G. D’Annunzio" School of Medicine, Chieti; and the Divisions of Cardiology, "S.S. Annunziata" Hospital, Chieti (M.P.), and "F. Renzetti" Hospital, Lanciano (D.D.G.), Italy.

Correspondence to Francesco Cipollone, MD, Centro per la Prevenzione dell’Aterosclerosi, Università degli Studi "G. D’Annunzio," Via Pescara 66, 66013 Chieti, Italy. E-mail fcipollone{at}unich.it

Background— The evidence that inflammation plays a pivotal role in the pathophysiology of acute coronary syndromes prompted us to investigate the effects of glucocorticoid treatment on leukotriene (LT) C4 and thromboxane (TX) A2 biosynthesis in unstable angina.

Methods and Results— Urinary LTE4 and 11-dehydro-TXB2 were significantly higher in 12 patients with unstable angina than in 12 patients with stable angina and 12 patients with nonischemic chest pain. Furthermore, we randomized the unstable angina patients to receive intravenous 6-methylprednisolone (6-MP; 1 mg/kg BID for 2 days) or matching placebo and collected 12 consecutive 6-hour urine samples before and during the infusions. LTE4 excretion showed a time-dependent decrease in the 6-MP group but did not decrease during placebo. Furthermore, during myocardial ischemia, LTE4 was significantly higher before 6-MP infusion than during steroid therapy. In contrast, 11-dehydro-TXB2 did not differ significantly during 6-MP versus placebo. Myocardial ischemia elicited by stress test in the stable angina patients was not accompanied by any change in LTE4 and 11-dehydro-TXB2, thus ruling out a role of ischemia per se in the induction of increased eicosanoid production.

Conclusions— Increased production of vasoactive LT and TX may occur in unstable angina despite conventional antithrombotic and antianginal treatment. Glucocorticoids can suppress LTC4 biosynthesis in the short term and may provide an interesting tool to explore the pathophysiological significance of inflammatory cell activation in this setting.


Key Words: angina • inflammation • prostaglandins • leukocytes • platelets




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Cipollone, A. Mezzetti, M. L. Fazia, C. Cuccurullo, A. Iezzi, S. Ucchino, F. Spigonardo, M. Bucci, F. Cuccurullo, S. M. Prescott, et al.
Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1665 - 1670.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Ferroni, S. Novo, V. Davi, G. Novo, S. Basili, G. Davi, F. Cipollone, and A. Mezzetti
Circulating Transforming Growth Factor-{beta}1 Levels in Asymptomatic Carotid Plaques * Response:
Stroke, March 1, 2005; 36(3): 525 - 526.
[Full Text] [PDF]


Home page
JAMAHome page
F. Cipollone, E. Toniato, S. Martinotti, M. Fazia, A. Iezzi, C. Cuccurullo, B. Pini, S. Ursi, G. Vitullo, M. Averna, et al.
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke
JAMA, May 12, 2004; 291(18): 2221 - 2228.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Cipollone, B. Rocca, and C. Patrono
Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis
Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 246 - 255.
[Abstract] [Full Text]